BRPI1014684A2 - novos derivados de isoquinolina - Google Patents

novos derivados de isoquinolina

Info

Publication number
BRPI1014684A2
BRPI1014684A2 BRPI1014684A BRPI1014684A BRPI1014684A2 BR PI1014684 A2 BRPI1014684 A2 BR PI1014684A2 BR PI1014684 A BRPI1014684 A BR PI1014684A BR PI1014684 A BRPI1014684 A BR PI1014684A BR PI1014684 A2 BRPI1014684 A2 BR PI1014684A2
Authority
BR
Brazil
Prior art keywords
isoquinoline derivatives
new isoquinoline
new
derivatives
isoquinoline
Prior art date
Application number
BRPI1014684A
Other languages
English (en)
Inventor
Guolong Wu
Li Chen
Lichun Feng
Yongguo Li
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI1014684A2 publication Critical patent/BRPI1014684A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI1014684A 2009-05-08 2010-05-05 novos derivados de isoquinolina BRPI1014684A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009071693 2009-05-08
PCT/EP2010/056062 WO2010128061A1 (en) 2009-05-08 2010-05-05 Novel isoquinoline derivatives

Publications (1)

Publication Number Publication Date
BRPI1014684A2 true BRPI1014684A2 (pt) 2016-04-12

Family

ID=42272377

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014684A BRPI1014684A2 (pt) 2009-05-08 2010-05-05 novos derivados de isoquinolina

Country Status (13)

Country Link
US (1) US8258149B2 (pt)
EP (1) EP2427460B1 (pt)
JP (1) JP2012526077A (pt)
KR (1) KR20120007549A (pt)
CN (1) CN102421774A (pt)
AU (1) AU2010244473A1 (pt)
BR (1) BRPI1014684A2 (pt)
CA (1) CA2760339A1 (pt)
ES (1) ES2462498T3 (pt)
IL (1) IL216062A0 (pt)
MX (1) MX2011011716A (pt)
SG (1) SG175926A1 (pt)
WO (1) WO2010128061A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102796096B (zh) * 2011-05-27 2016-09-14 中国科学院上海药物研究所 六氢二苯并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用
US9181237B2 (en) 2013-10-04 2015-11-10 Mallinckrodt Llc Substituted berbines and their synthesis
KR101656394B1 (ko) * 2013-12-31 2016-09-23 한국화학연구원 신규한 8-옥소프로토베르베린 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 nfat5의 활성 관련 질환의 예방 또는 치료용 약학적 조성물
WO2015102380A1 (ko) * 2013-12-31 2015-07-09 한국화학연구원 신규한 8-옥소프로토베르베린 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 nfat5의 활성 관련 질환의 예방 또는 치료용 약학적 조성물
CN117813305A (zh) * 2022-03-16 2024-04-02 南京施江医药科技有限公司 一种含氮杂环类化合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000021073A (ko) * 1998-09-25 2000-04-15 박원배 콜레스테롤 생합성 저해제
JP4774212B2 (ja) * 2002-11-12 2011-09-14 ラトガーズ、ザ・ステイト・ユニバーシテイ・オブ・ニユー・ジヤージー トポイソメラーゼ−ターゲッティング剤
CN1759834B (zh) * 2004-09-17 2010-06-23 中国医学科学院医药生物技术研究所 黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
US7572809B2 (en) * 2005-12-19 2009-08-11 Hoffmann-La Roche Inc. Isoquinoline aminopyrazole derivatives
CN101153039B (zh) 2006-09-30 2010-12-01 中国科学院上海药物研究所 13,13a-二氢小檗碱衍生物及其药物组合物和用途
CN100494193C (zh) * 2006-12-14 2009-06-03 西南大学 8-辛基小檗碱盐酸盐、合成方法及应用
CN101104618B (zh) * 2007-05-25 2010-05-26 西南大学 长链烷基小檗碱盐衍生物、合成方法及用途
US8003795B2 (en) * 2007-06-22 2011-08-23 Cvi Pharmaceuticals Limited Compounds and compositions for reducing lipid levels
EP2014651A1 (en) 2007-07-12 2009-01-14 Exonhit Therapeutics SA Compounds and methods for modulating Rho GTPases

Also Published As

Publication number Publication date
ES2462498T3 (es) 2014-05-23
EP2427460B1 (en) 2014-03-26
US8258149B2 (en) 2012-09-04
KR20120007549A (ko) 2012-01-20
MX2011011716A (es) 2012-01-03
JP2012526077A (ja) 2012-10-25
AU2010244473A1 (en) 2011-12-15
EP2427460A1 (en) 2012-03-14
WO2010128061A1 (en) 2010-11-11
US20100286396A1 (en) 2010-11-11
CA2760339A1 (en) 2010-11-11
SG175926A1 (en) 2011-12-29
IL216062A0 (en) 2012-01-31
CN102421774A (zh) 2012-04-18

Similar Documents

Publication Publication Date Title
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI1011683A2 (pt) derivado isoquinolina substituída
BR112012004969A2 (pt) derivados de bis-benzimidazol
BR112012002662A2 (pt) derivados de bis-benzimidazol
BRPI1013844A2 (pt) derivados de piridina-isoxazol
ECSP12011999A (es) Derivados benzamida sustituidos
BR112012000763A2 (pt) derivados de piridin-4-ila
DE112010002949A5 (de) Kupplungstastpunkte
BRPI1008774A2 (pt) espiroamida substituída
DK2397480T3 (da) Diazepindionderivat
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
DE112010002728A5 (de) Turboinhalator
DE112009005323A5 (de) Hebelarmprüfmaschine
DK2387580T3 (da) Deoxyactagardinderivater
BR112012000657A2 (pt) novos azabicilohexanos
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
BRPI1011416A2 (pt) derivados de antraquinova novos
BR112012002810A2 (pt) derivados de n1-acil-5-fluoropirimidinona
BRPI1007369A2 (pt) derivados de di-hidroquinolinona
FR2947857B1 (fr) Agencement de deshuileur

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]